Comparison
5p Partial Monosomy Syndrome C0010314 vs 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Clinical comparison between 5P Partial Monosomy Syndrome and 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia for differential diagnosis and treatment planning.
5p Partial Monosomy Syndrome C0010314
Also called Cri-du-chat syndrome, caused by a deletion on chromosome 5. Features include a high-pitched cry, developmental delay, and intellectual disability.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
An inherited disorder affecting adrenal hormone production, causing cortisol deficiency and other hormonal imbalances. Features may include ambiguous genitalia, salt-wasting crises, and growth issues. Treated with lifelong hormone replacement therapy.
6 comparison axes
Onset
5p Partial Monosomy Syndrome C0010314
0-0
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
0-null
Onset patterns differ
Severity
5p Partial Monosomy Syndrome C0010314
severe
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
severe
Different severity levels
Chronic
5p Partial Monosomy Syndrome C0010314
Chronic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Chronic
Differing course
Communicable
5p Partial Monosomy Syndrome C0010314
No
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
No
Different transmission
Body System
5p Partial Monosomy Syndrome C0010314
congenital
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
Same/different system
Category
5p Partial Monosomy Syndrome C0010314
genetic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
Different category
Bottom line
5p-partial-monosomy-syndrome-C0010314 and 21-hydroxylase-deficient-congenital-adrenal-hyperplasia-C2936858 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 5p Partial Monosomy Syndrome C0010314 | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | Discriminating power |
|---|---|---|---|
| High-pitched cry | A characteristic high-pitched cry is described. | Not a described feature. | High |
| Developmental and intellectual effects | Developmental delay and intellectual disability are described. | Not established by the supplied description. | Moderate |
| Genital and salt-balance features | Not described in the supplied source. | Ambiguous genitalia and salt-wasting crises may occur. | High |
When to favor each condition
Choose 5p Partial Monosomy Syndrome C0010314 when
Newborn with a high-pitched cry and developmental concerns
These features align with the supplied description of 5p partial monosomy.
Moderate
Suspected chromosomal deletion
The condition is described as caused by deletion on chromosome 5.
High
No adrenal crisis features are present
Absence of endocrine features does not prove the diagnosis and needs clinician review.
Low
Choose 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 when
Infant with possible salt-wasting crisis
Salt-wasting crises are described in 21-hydroxylase-deficient CAH.
Moderate
Ambiguous genitalia with suspected adrenal disorder
This feature may occur and warrants urgent endocrine assessment.
Moderate
Need for lifelong hormone replacement is being considered
The supplied description states treatment with lifelong hormone replacement.
High
How key tests differ
| Test | 5p Partial Monosomy Syndrome C0010314 | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | Interpretation |
|---|---|---|---|
| Chromosomal analysis | May identify a chromosome 5 deletion. | Not expected to establish this adrenal disorder. | A genetic result requires specialist interpretation. |
| Adrenal steroid testing | No characteristic result is established here. | May support cortisol deficiency and related imbalance; no cutoff is supplied. | Abnormal results are not themselves a complete diagnosis. |
| Electrolyte assessment | No specific pattern is established by the source. | May be abnormal during salt-wasting illness. | Results need urgent clinical correlation. |
Prognosis comparison
5p Partial Monosomy Syndrome C0010314
- Outcome
- A chronic, severe congenital condition is described; exact outcomes are not established.
- Factors
- Developmental delay and intellectual disability may influence support needs.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
- Outcome
- A chronic, severe endocrine condition is described; exact outcomes are not established.
- Factors
- Hormone imbalance, salt-wasting risk, growth issues, and treatment adherence may matter.
Time frame: Both are described as chronic; precise timelines are not supplied.
Prognosis should be individualized by clinicians using confirmed diagnosis and clinical course.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental disability | Developmental delay and intellectual disability are described. Not established in the supplied description. Support needs vary and should be individualized. |
| Acute salt-wasting illness | Not described. Salt-wasting crises may occur. This can be an emergency requiring clinician-directed care. |
| Growth concerns | Not specifically established here. Growth issues may occur. Growth assessment should be interpreted clinically. |
Patient education highlights
- HighDifferent causes
One is a chromosome 5 deletion; the other is an inherited adrenal hormone disorder.
- HighUrgent symptoms
Suspected salt-wasting, severe illness, or feeding problems need prompt medical care.
- MediumLong-term care
CAH is described as treated with lifelong hormone replacement; developmental support may be relevant for 5p deletion.